Pharmaceutical industry news

Invasive mosquito species detected in east London

UKHSA finds invasive Aedes aegypti breeding in east London, prompting enhanced surveillance.

Titan Biotech jumps 5% on 1:4 bonus issue, dividend announcements

Flu vaccines: 2026 to 2027 flu season

Flu vaccines available for the 2026 to 2027 flu season and the clinical risk groups that they apply...

Two ERC Starting Grants for Scientists at Universität Heidelberg

Shaping the future of pharma: GELITA’s next-gen excipients at CPHI

Ureteric stent removal after a kidney transplant

Titan Biotech's Board Approves Issuance Of Bonus Shares In Ratio Of 1:4

AI sleep data could provide one-week early warning of flu and COVID-19

UKHSA study finds sleep app cough data can detect respiratory illness and signal outbreaks early.

Children’s public health nursing: workforce and activity, 2025

Official statistics in development on healthy child programme activity, school nursing services and...

Daewoong Pharmaceutical deepens cooperation with Indonesia’s regulator

Ultragenyx Angelman syndrome drug fails Phase III test

Federal judge pauses case on mifepristone access until after midterm elections

Daewoong steps up cooperation with Indonesia

Danish pension giants increased Novo Nordisk stakes in H1

Free Science – Successful Economy – Strong Germany

Engagement guide for infection and antimicrobial resistance (AMR)

A UK-wide collaborative guide giving engagement and communication approaches to raise awareness of A...

La AEMPS informa de un riesgo de acceso no autorizado en el sistema Albert e-motion M25 de accionamiento adicional para sillas de ruedas

Balancing tried-and-tested against future innovation – a strategy for boosting earlier cancer diagnosis

Adult social care provider statistics, England: quarterly update to August 2026

Official statistics on the number of people receiving adult social care services, and information on...

Adult social care provider statistics, England: background quality and methodology

How the Department of Health and Social Care (DHSC) puts together the statistics in its quarterly re...

Adult social care provider statistics, England: quarterly update

Official statistics on topics including occupancy and flu vaccination in adult social care settings...

Surveillance of respiratory syncytial virus: winter 2024 to 2025

An annual overview of respiratory syncytial virus (RSV) surveillance results from the winter period.

Respiratory syncytial virus (RSV) older adults vaccination coverage in England

Vaccine uptake data for the respiratory syncytial virus (RSV) vaccination programme for older adults...

Respiratory syncytial virus (RSV) maternal vaccination coverage in England

Official statistics data and reporting on vaccine uptake for the RSV (respiratory syncytial virus) v...

HIV: London annual data spotlight

Reports presenting annual epidemiological data for HIV in London.

Why the Energy Transition needs interdisciplinary thinking

WuXi Biologics: Enabling the Next Phase of Complex Molecule Innovation

Synpedagogen ger vardagen kontrast och struktur

Mosquito control

How to control mosquitoes in residential settings where there may be standing water.

Connected trials

Biotech Stocks At 52-Week Highs - OABI +13%, FRNM, EXEL, FTH, LFST

AI methods for regulator-ready real-world evidence in NSCLC

Annji Submits Application To U.S. FDA For Phase 3 Clinical Trial Of AJ201

La AEMPS informa del cese de comercialización, retirada del mercado y recuperación de varios lotes de FluorKin infantil fresa enjuague bucal por contaminación microbiológica

Russia strikes Ukraine's largest pharmaceutical warehouse: losses could reach billions

Ivonescimab Meets Overall Survival Endpoint Against Pembrolizumab in Phase III Trial

Fortrea’s $45M Early-Phase Acquisition Will Reshape Your Phase I Startup Timeline — Are You Ready?

Bulgarian pharma industry protests overt 'politicisation' of medicines policy

NSABP B-59 Failed. The Real Question Is Why We Keep Designing Trials That Can’t Detect the Signal.

Ultragenyx's Angelman syndrome drug fails pivotal Phase 3 trial

RARE Looks 41.3% Undervalued on GF Value™ After Phase 3 Setback

Titan Biotech Board Approves Bonus Share Issuance

Making Rotterdam my home

Université Paris Cité on the path to internationalising its programmes

COVID-19 cases are rising: How to protect yourself this fall and winter

Volunteers help older patients stay connected and clear-minded during hospital stays

TENDER NOTICE SUPPLY AND DELIVERY OF VARIOUS MEDICAL EQUIPMENT Amref Health Africa in Kenya TENDER NO. AMREF /03/09/2026/013

Short competence development courses give natural science teaching in primary and secondary schools a boost

TScan Therapeutics cuts 75% of workforce, pauses Phase 3 ALLOHA-2 trial for TSC-101

Nanochon Enrolls First Patient in Chondrograft Knee Cartilage Study

Inventiva Completes NATiV3 Phase 3 Trial of Lanifibranor in MASH

Pharmaceutical warehouse reported on fire after Russian drone attack in Ukraine’s Boryspil

Indonesian Regulator Visits Daewoong Research Center

Déployer la médecine génomique

Vessl AI supplies SK Biopharmaceuticals 128 Nvidia B200 GPUs to fuel R&D - CHOSUNBIZ

Ultragenyx drops on Phase 3 trial failure for Angelman syndrome drug (RARE:NASDAQ)

Korea United Pharmaceutical succeeded in re-certifying the Ukrainian drug manufacturing and quality

How to avoid common contamination control mistakes in new aseptic facilities

Mint Venture Partners Lists Three Biotech Bets on KOSDAQ

GSK agrees to pay $110 million for HUTCHMED cancer-drug rights